Fernandez, Ana .

HRN: 22-12-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/29/2022
CEFTRIAXONE 1G (VIAL)
12/29/2022
01/04/2023
IV
2g
OD
F/C Hepatic Encephalopathy, UTI
Waiting Final Action 
12/29/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/29/2022
01/04/2023
IVT
500mg
Q8
T/C Hepatic Encephalopathy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: